SCHEMBL23326259

SCHEMBL23326259

O=C1c2ccccc2C(=O)N1C1C=Cc2cccc3cccc1c23

nearest known ligand 0.38

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MEN1 O00255 4/20 0.38
KMT2A Q03164 4/20 0.38
MAPT P10636 2/20 0.38
MAPK1 P28482 1/20 0.38
ERCC1 P07992 1/20 0.38
FEN1 P39748 1/20 0.38
ERCC4 Q92889 1/20 0.38
ALDH1A1 P00352 6/20 0.36
NPSR1 Q6W5P4 1/20 0.36
CES2 O00748 1/20 0.35
BCHE P06276 1/20 0.35
CES1 P23141 1/20 0.35
MCL1 Q07820 1/20 0.35
CYP3A4 P08684 1/20 0.35
PABPC1 P11940 1/20 0.35
DNMT1 P26358 1/20 0.35
CASP1 P29466 1/20 0.35
CASP7 P55210 1/20 0.35
KDM4E B2RXH2 3/20 0.35
HPGD P15428 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL27773908 0.84 MEN1 (0.33) MEN1KMT2AMAPTMAPK1
SCHEMBL345741 0.73 ALDH1A1 (0.35) MEN1KMT2AMAPTMAPK1ERCC1
SCHEMBL21994384 0.73 CYP1A2 (0.32) ALDH1A1HPGDHSD17B10
SCHEMBL20504478 0.70 ALDH1A1 (0.43) MEN1KMT2AMAPTALDH1A1CYP3A4
SCHEMBL28754378 0.70 USP2 (0.41) KMT2AALDH1A1KDM4EHPGDHSD17B10
SCHEMBL11035480 0.69 ALDH1A1 (0.36) MEN1KMT2AMAPTMAPK1ALDH1A1
SCHEMBL28982397 0.68 BRD4 (0.42) MEN1KMT2AMAPTALDH1A1CYP3A4
Benzoquinone SCHEMBL28848136 0.67 MEN1 (0.31) MEN1KMT2AMAPTMAPK1ERCC1
SCHEMBL17188010 0.66 ALDH1A1 (0.33) MEN1KMT2AALDH1A1CYP3A4HPGD
SCHEMBL15322808 0.66 ALDH1A1 (0.33) ALDH1A1CYP3A4HPGDHSD17B10CYP1B1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-11918653-B2 Triglyceride otic formulations and uses thereof DOMPÉ FARMACEUTICI S.P.A. (IT) 2024-03-05 US disclosed
US-20210138069-A1 TRIGLYCERIDE OTIC FORMULATIONS AND USES THEREOF DOMPÉ FARMACEUTICI S.P.A. (IT) 2021-05-13 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20210138069-A1 TRIGLYCERIDE OTIC FORMULATIONS AND USES THEREOF CETP, LIPA, APOB MEN1 1519/4885KMT2A 3482/4885MAPT 2438/4885
US-11918653-B2 Triglyceride otic formulations and uses thereof CETP, LIPA, APOB MEN1 1519/4885KMT2A 3482/4885MAPT 2438/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.